Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Ocata Therapeutics, Inc. | v177442_10k.htm |
| EX-31.1 - EX-31.1 - Ocata Therapeutics, Inc. | v177442_ex31-1.htm |
| EX-23.1 - EX-23.1 - Ocata Therapeutics, Inc. | v177442_ex23-1.htm |
| EX-10.135 - EX-10.135 - Ocata Therapeutics, Inc. | v177442_ex10-135.htm |
EXHIBIT
32.1
CERTIFICATIONS
OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, William
M. Caldwell, IV, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, certify that the annual report
on Form 10-K of Advanced Cell Technology, Inc. for the fiscal year ended
December 31, 2009 fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that
information contained in such report fairly presents, in all material respects,
the financial condition and results of operations of Advanced Cell Technology,
Inc.
|
Dated:
March 16, 2010
|
By:
|
/s/ William M. Caldwell,
IV
|
|
William
M. Caldwell, IV
|
||
|
Principal
Executive Officer,
Principal
Financial Officer
|